Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Sichuan Kelun Pharmaceutical (002422 CH)
Watchlist
87
Analysis
Health Care
•
China
Sichuan Kelun Pharmaceutical Co., Ltd. manufactures pharmaceutical products. The Company's products include large infusion products, tablets, capsules, antibiotic injection, lyophilized powder for injection, and traditional Chinese medicine.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Sichuan Kelun Pharmaceutical
•
25 Sep 2024 08:55
Sichuan Kelun Pharmaceutical (002422.CH) - The Real Breakthrough Point in Valuation Is ADC Pipeline
Kelun's traditional businesses lack imagination, but Kelun-bio's ADC pipeline is a highlight. Valuation may not be high due to lost pricing power...
Xinyao (Criss) Wang
Follow
344 Views
Share
bullish
•
Greatview Aseptic Packaging
•
15 Dec 2024 09:05
China Healthcare Weekly (Dec.15) - 10th VBP Results, WuXi Shares Surge, Newjf Will Be Successful
10th national VBP results show 70% price reduction. WuXi shares surge without BIOSECURE Act in US NDAA amendments, but rally may be short...
Xinyao (Criss) Wang
Follow
422 Views
Share
bullish
•
Sieyuan Electric Co Ltd A
•
13 Dec 2024 06:23
CSI300/CSI500/CSI1000 Index Rebalance: US$9bn Round-Trip Trade
The CSI indices (and a bunch of others) rebalance at the close today - it's going to be a big volume day in China. The CSI300 adds have...
Brian Freitas
Follow
773 Views
Share
bearish
•
Shanghai Fosun Pharmaceutical (Group)
•
10 Dec 2024 08:55
Shanghai Fosun Pharmaceutical (2196.HK) - Performance Pain Points and Henlius’ Privatization Outlook
Fosun Pharma's investment-driven business model relies heavily on subsidiaries.Privatization of Henlius may face uncertainties if not prioritized...
Xinyao (Criss) Wang
Follow
413 Views
Share
bullish
•
China Resources Pharmaceutical
•
24 Nov 2024 10:13
China Healthcare Weekly (Nov.24) - 10th VBP, Biotech Valuation Logic, China Resources Reorganization
The 10th national VBP kicks off. Chinese Biotech face valuation discount when included in global valuation system. China Resources is undergoing...
Xinyao (Criss) Wang
Follow
513 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3
x